Invesaro

Stocks Health care ESTA

NASDAQ · Health care

Establishment Labs Holdings Inc. (ESTA)

Establishment Labs Holdings Inc. brought in $245.8M of revenue over the twelve months to June 30, 2026, up 38.6% from a year earlier. It posted a net loss of $38.9M. In fiscal 2025 capital spending exceeded operating cash flow by $56.9M. At June 30, 2026 it held $71.2M in cash against $261.7M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 7, 2026.

Price
$65.97
+0.60% on the day · September 25, 2026
52-week range $38.35 to $97.59
Market cap
$2B
Revenue (last 12 months)
$245.8M
+38.6% year on year
Net margin
-15.8%

What Establishment Labs Holdings Inc. does

Establishment Labs Holdings Inc. is registered with the SEC under industry code SIC 3842 (Orthopedic, Prosthetic & Surgical Appliances & Supplies). Its shares trade on NASDAQ under the ticker ESTA.

Revenue and profit by year

Revenue
FY18: $61.2M $61.2M FY18FY19: $89.6M $89.6M FY19FY20: $84.7M $84.7M FY20FY21: $126.7M $126.7M FY21FY22: $161.7M $161.7M FY22FY23: $165.2M $165.2M FY23FY24: $166M $166M FY24FY25: $211.1M $211.1M FY25
Net income
FY18: -$21.1M -$21.1M FY18FY19: -$38.2M -$38.2M FY19FY20: -$38.1M -$38.1M FY20FY21: -$41.1M -$41.1M FY21FY22: -$75.2M -$75.2M FY22FY23: -$78.5M -$78.5M FY23FY24: -$84.6M -$84.6M FY24FY25: -$51.1M -$51.1M FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025$211.1M-$39M-$51.1M-$1.72-$56.9M
2024$166M-$50M-$84.6M-$3.00-$64.6M
2023$165.2M-$65M-$78.5M-$3.07-$96.4M
2022$161.7M-$39.7M-$75.2M-$3.08-$55M
2021$126.7M-$25.1M-$41.1M-$1.72-$30M
2020$84.7M-$27.9M-$38.1M-$1.63-$14.6M
Next report expected around November 4, 2026.

Estimated from its filing rhythm: 52 weeks after its report of November 5, 2025. Not a date the company has announced. See the report calendar

Where ESTA ranks in Health care

Revenue$211.1M
#250 of 523 in Health care · Top 48%
Revenue growth+27.1%
#126 of 437 in Health care · Top 29%
Net margin-24.2%
#278 of 447 in Health care · Bottom 38%
Free cash flow margin-27.0%
#285 of 408 in Health care · Bottom 30%

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Health care

Latest SEC filings

What Establishment Labs Holdings Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. August 7, 2026
    Quarterly report 10-Q · period to June 30, 2026
  2. August 6, 2026
  3. July 31, 2026
  4. July 28, 2026
  5. June 29, 2026
  6. May 22, 2026
  7. May 15, 2026
  8. May 8, 2026
    Quarterly report 10-Q · period to March 31, 2026
  9. May 6, 2026
  10. April 30, 2026

Recent insider filings (Forms 3, 4 and 144): 10, the latest on August 26, 2026. Insider transactions on SEC

Insider trades

What the people running Establishment Labs Holdings Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.

No insider bought or sold shares on the open market in the last 90 days. The 1 reported changes were pay in shares, option exercises, shares withheld for tax or gifts.

Bought (open market)
$0
last 90 days
Sold
$0
last 90 days
DateInsiderWhatSharesPriceValueFiling
August 20, 2026 Caldini FilippoChief Executive Officer, Director Shares withheld for tax 682 $71.52 $48.8K Form 4

All insider filings on SEC.gov · Where insiders are buying across the market

All filings on SEC EDGAR

Questions about ESTA

What does Establishment Labs Holdings Inc. do?

Establishment Labs Holdings Inc. is registered with the SEC under industry code SIC 3842 (Orthopedic, Prosthetic & Surgical Appliances & Supplies). Its shares trade on NASDAQ under the ticker ESTA.

Is Establishment Labs Holdings Inc. profitable?

No. Over the twelve months to June 30, 2026 it reported a net loss of $38.9M on revenue of $245.8M.

How much revenue does Establishment Labs Holdings Inc. make?

Over the twelve months to June 30, 2026 Establishment Labs Holdings Inc. reported revenue of $245.8M. That is 38.6% more than a year earlier.

When did Establishment Labs Holdings Inc. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 7, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the insider trade from August 26, 2026.

Similar companies

Compare ESTA with

Compare ESTA with any company

Follow ESTA

Get an email when Establishment Labs Holdings Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Follow ESTA: get an email when it files

Where the numbers come from

Financial figures are the values Establishment Labs Holdings Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.